Fundacion Clinica Shaio, Bogota, Colombia Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00123916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fundación Clínica Shaio

Active Ingredients

Drugs in Phase 4 Trials (2)

heparin (liquaemin) (1 trial)

protamine sulfate (1 trial)

Drugs in Phase 3 Trials (1)

benznidazole (Rochagan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chagas Disease (Phase 3)

Heart Diseases (Phase 3)

Trypanosomiasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3